Avanos Medical AVNS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | |||||
| PM&R | $9.2M+241% | $2.7M+173% | -$3.7M— | —— | |
| Total Specialty Nutrition Systems | $82.6M+2.2% | $80.8M+1.0% | $80M— | —— | |
| Net Sales by Product | |||||
| Enteral feeding | $314.7M+8.6% | $289.7M+2.3% | $283.3M— | —— | |
| Neonate solutions | $118.2M+10.8% | $106.7M+20.8% | $88.3M— | —— | |
| Radiofrequency ablation | $139M+10.1% | $126.2M+14.9% | $109.8M— | —— | |
| Surgical pain and recovery | $98.8M-8.5% | $108M-8.1% | $117.5M-26.6% | $160.1M-1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
